Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy

Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologi...

Source: BMC Pulmonary Medicine - March 21, 2024 Category: Respiratory Medicine Authors: Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, Christopher A. Hinze, Nora Drick, Nikolaus Kneidinger, J ürgen Behr, Christian Taube, Tobias Welte, Ina Haasler and Katrin Milger Tags: Research Source Type: research